USPTO Confirms the Validity of a Second Tenofovir Patent
Gilead Announces that USPTO to Uphold One of the Viread Patents
Tenofovir Patent Takes Another Hit
Patent Granted for Raltegravir in India
USPTO finds Gilead’s Tenofovir patents invalid following re-examination request by PUBPAT
Unravelling the Valganciclovir patent question in India
Unravelling the Valganciclovir patent question in India
Raltegravir application still pending in India
How do we increase transparency on granted drug patents?
GSK withdraws its application for Abacavir in India